Literature DB >> 3337000

Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis.

T A Kelly1, R M Rothbart, C M Cooper, D L Kaiser, M L Smucker, R S Gibson.   

Abstract

A 2-part prospective study was performed to evaluate the clinical outcome of patients with hemodynamically confirmed asymptomatic valvular aortic stenosis (AS). During phase 1, linear regression analysis showed continuous wave Doppler to be highly accurate in predicting catheterization measured peak systolic aortic valve pressure gradients in 101 consecutive patients aged 36 to 83 years (mean 65 +/- 8) with symptomatic AS. During phase 2, 90 additional patients (51 asymptomatic and 39 symptomatic) with Doppler-derived peak systolic aortic valve gradients greater than or equal to 50 mm Hg (range 50 to 132 [mean 68 +/- 19]) were followed for 1 to 45 months. Both groups of patients in phase 2 had similar Doppler gradients and clinical and auscultatory evidence of moderate to severe AS at baseline. Asymptomatic patients were younger (p = 0.01), had higher ejection fractions (p = 0.001) and were less likely to have an electrocardiographic strain pattern (p = 0.01) and left atrial enlargement (p = 0.02). End-diastolic wall thickness, left ventricular cross-sectional myocardial area and estimated left ventricular mass were 18% (p = 0.0001), 20% (p = 0.0008), and 29% (p = 0.002) greater in symptomatic patients. During 17 +/- 9 months of follow-up, 21 asymptomatic patients (41%) became symptomatic. Dyspnea was the most common initial complaint, occurring 2.5 and 4.8 times more often than angina and syncope, respectively. Compared with the 39 symptomatic patients, the 51 asymptomatic patients had a lower cumulative life table incidence of death from any cause (p = 0.002), and from cardiac causes (p = 0.0001) including sudden death (p = 0.013).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3337000     DOI: 10.1016/0002-9149(88)91317-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  31 in total

1.  To operate or not on elderly patients with aortic stenosis: the decision and its consequences.

Authors:  B J Bouma; R B van Den Brink; J H van Der Meulen; H A Verheul; E C Cheriex; H P Hamer; E Dekker; K I Lie; J G Tijssen
Journal:  Heart       Date:  1999-08       Impact factor: 5.994

2.  Aortic Stenosis.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-04

3.  Transarterial aortic valve replacement with a self expanding stent in pigs.

Authors:  M Ferrari; H R Figulla; M Schlosser; I Tenner; I Frerichs; C Damm; V Guyenot; G S Werner; G Hellige
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

4.  Robert Ogden Bonow, MD: a conversation with the editor on valvular heart disease and indications for operative intervention. Interview by William Clifford Roberts.

Authors:  Robert Ogden Bonow
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-01

Review 5.  Problems in the diagnosis and investigation of aortic stenosis.

Authors:  A Bishop; P Wilkinson
Journal:  Postgrad Med J       Date:  1991-12       Impact factor: 2.401

Review 6.  Asymptomatic valvular disease: who benefits from surgery?

Authors:  Naomi F Botkin; Paula S Seth; Gerard P Aurigemma
Journal:  Curr Cardiol Rep       Date:  2005-03       Impact factor: 2.931

Review 7.  Management of asymptomatic aortic stenosis: masterly inactivity but cat-like observation.

Authors:  J C Vaile; M J Griffith
Journal:  Heart       Date:  1997-09       Impact factor: 5.994

8.  Selection of prosthetic heart valves.

Authors:  Robert P Gallegos
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-12

9.  Asymptomatic severe aortic stenosis with left ventricular dysfunction: watchful waiting or valve replacement?

Authors:  Larry E Miller; Valerie M Miller; Larry D Acers
Journal:  Clin Med Res       Date:  2013-04-11

10.  Management of asymptomatic severe aortic stenosis.

Authors:  Robert L Stewart; Kwan L Chan
Journal:  Curr Cardiol Rev       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.